Impactful Mutations in Mpro of the SARS-CoV-2 Proteome

被引:0
|
作者
Wolfe, Gideon [1 ]
Belhoussine, Othmane [1 ]
Dawson, Anais [1 ]
Lisaius, Maxwell [1 ]
Jagodzinski, Filip [1 ]
机构
[1] Western Washington Univ, Bellingham, WA 98225 USA
关键词
SARS-CoV-2; mutations; computational biology;
D O I
10.1145/3388440.3414706
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
We explore how amino acid mutations affect the stability of the 306 residue main protease of the COVID-19 proteome. We employ two computational approaches, Site Directed Mutagenesis (SDM) and short runs of Molecular Dynamics. We focus our attention on residues 25-32 that make up a beta sheet of a canonical beta barrel close to an active site which includes Histidine 41. We considered this region a good candidate for mutations because such a large perturbation of a highly structured region close to the active site may prove to be highly detrimental to the protein's stability and may affect catalytic efficiency. Understanding how amino acid mutations affect the stability of the protein can inform efforts to develop pharmacological interventions. We mutated the 8 residues in silico to all other possible amino acids, and analyzed the resulting 152 mutants. Both computational methods predict that only a few specific mutations to some of the 8 residues have a major effect on the structural stability of the protein.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Partial immunity and SARS-CoV-2 mutations
    Hanage, William P.
    Russell, Colin A.
    SCIENCE, 2021, 372 (6540) : 354 - 354
  • [42] Effects of mutations on SARS-CoV-2 fitness
    Chirigati, Fernando
    NATURE COMPUTATIONAL SCIENCE, 2022, 2 (07): : 412 - 412
  • [43] Molnupiravir linked to SARS-CoV-2 mutations
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2023, 23 (11): : E476 - E476
  • [44] Mutations Strengthened SARS-CoV-2 Infectivity
    Chen, Jiahui
    Wang, Rui
    Wang, Menglun
    Wei, Guo-Wei
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (19) : 5212 - 5226
  • [45] SARS-CoV-2 Mutations and their Viral Variants
    Cosar, Begum
    Karagulleoglu, Zeynep Yagmur
    Unal, Sinan
    Ince, Ahmet Turan
    Uncuoglu, Dilruba Beyza
    Tuncer, Gizem
    Kilinc, Bugrahan Regaip
    Ozkan, Yunus Emre
    Ozkoc, Hikmet Ceyda
    Demir, Ibrahim Naki
    Eker, Ali
    Karagoz, Feyzanur
    Simsek, Said Yasin
    Yasar, Bunyamin
    Pala, Mehmetcan
    Demir, Aysegul
    Atak, Irem Naz
    Mendi, Aysegul Hanife
    Bengi, Vehdi Umut
    Sevel, Guldane Cengiz
    Altuntas, Evrim Gunes
    Kilic, Pelin
    Demir-Dora, Devrim
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 63 : 10 - 22
  • [46] Mutations, variants and strains of SARS-CoV-2
    Gamero-de-Luna, E. J.
    Gamero-Estevez, E.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (03): : 208 - 209
  • [47] Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
    Papaj, Katarzyna
    Spychalska, Patrycja
    Kapica, Patryk
    Fischer, Andre
    Nowak, Jakub
    Bzowka, Maria
    Sellner, Manuel
    Lill, Markus A.
    Smiesko, Martin
    Gora, Artur
    PLOS ONE, 2022, 17 (01):
  • [48] De Novo design of potential inhibitors against SARS-CoV-2 Mpro
    Li, Shimeng
    Wang, Lianxin
    Meng, Jinhui
    Zhao, Qi
    Zhang, Li
    Liu, Hongsheng
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 147
  • [49] Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro
    Hussain, A.
    NEW MICROBES AND NEW INFECTIONS, 2022, 47
  • [50] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Soumya Gulab Katre
    Alpana Jagdish Asnani
    Kumar Pratyush
    Nilima Gangadhar Sakharkar
    Ashwini Gajanan Bhope
    Kanchan Tekram Sawarkar
    Vaibhav Santosh Nimbekar
    Future Journal of Pharmaceutical Sciences, 8